4TEEN4 Trademark

Trademark Overview


On Friday, February 14, 2025, a trademark application was filed for 4TEEN4 with the United States Patent and Trademark Office. The USPTO has given the 4TEEN4 trademark a serial number of 79420334. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Tuesday, July 29, 2025. This trademark is owned by 4TEEN4 Pharmaceuticals GmbH. The 4TEEN4 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of sepsis, septic shock and cardiogenic shock; antibodies for the prevention and treatment of sepsis, septic shock and cardiogenic shock; antibodies for use as components in diagnostic assays for the detection of biomarkers in body fluids; diagnostic preparations for the detection of biomarkers in body fluids; diagnostic immunoassays for medical use for the detection of biomarkers in body fluids; immunoassay reagents for medical use for the detection of biomarkers in body fluids

Research and development in the pharmaceutical and biotechnology fields; medical research; research and development in the field of therapeutics for the treatment of sepsis, septic shock, and cardiogenic shock
4teen4

General Information


Serial Number79420334
Word Mark4TEEN4
Filing DateFriday, February 14, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateTuesday, July 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkFOR TEEN FOR
Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of sepsis, septic shock and cardiogenic shock; antibodies for the prevention and treatment of sepsis, septic shock and cardiogenic shock; antibodies for use as components in diagnostic assays for the detection of biomarkers in body fluids; diagnostic preparations for the detection of biomarkers in body fluids; diagnostic immunoassays for medical use for the detection of biomarkers in body fluids; immunoassay reagents for medical use for the detection of biomarkers in body fluids
Pseudo MarkFOUR TEEN FOUR
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; medical research; research and development in the field of therapeutics for the treatment of sepsis, septic shock, and cardiogenic shock

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 28, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Name4TEEN4 Pharmaceuticals GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressHennigsdorf 16761
DE

Trademark Events


Event DateEvent Description
Thursday, March 27, 2025SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Friday, March 28, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sunday, March 30, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, July 22, 2025ASSIGNED TO EXAMINER
Sunday, March 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 29, 2025NON-FINAL ACTION WRITTEN
Wednesday, July 30, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW